AARP Georgia State Director, Debra Tyler-Horton, released the following statement today, applauding Reps. Sanford Bishop, Hank Johnson, John Lewis, Lucy McBath, and David Scott, of the U.S. House of Representatives for voting to pass H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act.
WASHINGTON—Retail prices for 267 brand-name drugs commonly used by older adults surged by an average of 5.8% in 2018, more than twice the general inflation rate of 2.4%, according to new AARP Public Policy Institute (PPI) data released today. The annual average cost of therapy for one brand-name drug ballooned to more than $7,200 in 2018, up from nearly $1,900 in 2006.
Your eyes aren’t tricking you: AARP’s drug-price-fighting Tyrannosaurus Rexes—known as the “Rx T. Rex”—are back and roaring about their mission to make high drug prices extinct. This time the mighty dinos are stomping around Capitol Hill and all across the nation, urging Congress to take a bite out of high drug prices.
On Thursday, Sept. 26, AARP Georgia and the Department of Veterans Affairs (VA) hosted a Telehealth Forum at the Cobb Galleria Centre. The Telehealth Forum provided information to AARP members, Caregivers, and Veterans about how to utilize telehealth technology.
CHICAGO—AARP today released new data and an infographic illustrating the impact of high prescription drug prices on Americans, specifically people living with cancer, prediabetes or diabetes, and heart disease. AARP unveiled the infographic at the National Academy for State Health Policy (NASHP) annual conference as part of AARP’s nationwide Stop Rx Greed campaign to lower drug prices.